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Despite primary and secondary methods for the prevention of acute coronary 
syndromes, there is still poor patient and physician understanding of the importance 
of smoking cessation. Cardiovascular risk decreases significantly after smoking ces-
sation, however, there is a paucity of counseling programs regarding this issue after 
hospitalization. Such programs have proved to be cost effective and should be provided 
as standard care. 
Similarly there is abundant clinical evidence that lowering of LDL cholesterol is 
of paramount importance in secondary prevention. Most recent clinical trials have 
extended the benefits of lipid lowering drugs (HMG-CoA reductase inhibitors) to 
individuals without known atherosclerotic disease and with average levels of choles-
terol. While the current Adult Treatment Panel III defines optimal LDL cholesterol 
as below 100 mg/dL, the optimal plasma levels for achieving the lowest cardiovascular 
risk may be considerably lower. Because drug therapy will almost certainly prove 
neither cost effective nor medically appropriate in primary prevention, especially in 
younger populations, intensive life-style modification should become a society priority. 
However, even medically treated patients under physician’s guidance do not reach the 
aforementioned levels. 
We examined 88 patients who suffered from an acute coronary syndrome from 
January to March of 2007 and had a telephone or personal contact to determine their 
smoking status and total cholesterol and LDL levels. The study included 11 women and 
77 men, with average age of 62.5 years (range, 24-80 years). Forty two patients were 
smokers and 7 were dyslipidaimic with or without statin therapy (75 vs 13). Patients 
over 80 years old were excluded. After one year follow up, 6 patients died (50% of 
them were smokers). In the smokers group, 54% of had quit smoking after one year 
(21 patients), 3% of patients were on statin therapy (n=76) and 64% (n=53) reached 
plasma LDL value<100mg/dl. 
In conclusion the current strategy of cardiovascular risk modification to prevent a 
new acute coronary syndrome is far away from the national published guidelines. 
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